Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury

NeuroRehabilitation

Volumn 18, Issue 3, 2003, Pages 205-208

  Krieger, Deborah ^a   Hansen, Keith ^b   McDermott, Colleen ^c   Matthews, Roy ^b   Mitchell, Rachel ^b   Bollegala, Natasha ^b   Bhalerao, Shree ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain injury; Delirium; Loxapine; Neuroleptic; Olanzapine

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DIAZEPAM; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PROPRANOLOL; SERTRALINE;

ADULT; ARTICLE; BRAIN INJURY; BRAIN SURGERY; CASE REPORT; DELIRIUM; DYSARTHRIA; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MALE; MENTAL HEALTH; NEUROLOGIC EXAMINATION; RESTLESSNESS; SEDATION; SIDE EFFECT; SPEECH; TREATMENT OUTCOME;

EID: 0141427681     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2003-18304     Document Type: Article

References (13)

1. American Psychiatric Association. Diagnostic criteria from DSM-IV. Washington DC: American Psychiatric Association, 1994.
2. American Psychiatric Association. Practice guidelines for the treatment of patients with delirium, American Journal of Psychiatry 156(5) (1999), 1-20.
3. M. Fenton, B. Murphy, J. Wood, A.M. Bagnall, P. Chue and M. Leitner, Loxapine for schizophrenia, The Cochrane Library (2000), 3.
4. J.M. Flacker and L.A. Lipsitz, Neural mechanisms of delirium: Current hypothesis and evolving concepts, Journal of Gerontology: Biological Sciences 54A(6) (1999), B239-B246.
5. S. Kapur, R. Zipursky and G. Remington, Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia, American Journal of Psychiarty 156(2) (1999), 286-293.
6. S. Kapur, R. Zipursky, G. Remington, C. Jones and S. Houle, PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: Implications for the therapeutics of schizophrenia, American Journal of Psychiatry 154(11) (1997), 1525-1529.
7. S. Kapur, R. Zipursky, G. Remington, A. Wilson and S. Houle, 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation, American Journal of Psychiatry 155(7) (1998), 921-928.
8. V. Rao, Neuropsychiatric sequelae of traumatic brain injury, Psychosomatics 41(2) (2000), 95-103.
9. T.A. Rummans, E.M. Evans, L.E. Krahn and K.C. Fleming, Delirium in Elderly Patients: Evaluation and management, Mayo Clinic Proc 70 (1995), 989-998.
10. J.M. Silver, R.E. Hales and S.C. Yudofsky, Neuropsychiatric aspects of traumatic brain injury. American Psychiatric Press, Washington, DC 1992.
11. J.M. Silver, S.C. Yudofsky amd R.E. Hales, Depression in traumatic brain injury. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 4 (1991), 12-23.
12. J.M. Silver, S.C. Yudofsky and R.E. Hales, Neuropsychiatry of traumatic brain injury. American Psychiatric Press, Washington, DC 1994.
13. S.T. O'Keeffe and J.N. Lavan, Clinical significance of delirium subtypes in older people, Age and Ageing 28 (1999), 115-119.